Page 3 - Insulin Value Program News Today

The changes will affect name-brand and nonbranded insulin, with prices for Humulin and Humalog insulin set to also fall later this year.

Pharmaceutical company Eli Lilly announced a series of price cuts that would lower the price of the most commonly used forms of its insulin.

Life-saving insulin will be more affordable in the future after drug maker Eli Lilly announced plans to cap its prices.

These drug makers have been criticized for their high prices, up significantly since they began selling analog insulin products 20 years ago.

Pharmaceutical giant Eli Lilly has announced it is instituting a $35 dollar monthly cap on out-of-pocket insulin expenses.

Eli Lilly and Company announced price reductions of 70% for its most commonly prescribed insulins and caps patient out-of-pocket costs at $35

Eli Lilly has announced that it is reducing the list price of its insulin by 70% and capping out-of-pocket costs at $35 a month as part of its Insulin Value Program. Effective immediately, Lilly will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin. Lilly is cutting the list price of its

Plus, a concerning rise in colorectal cancer among young people, what Chicago voters signaled to the rest of the country, and more.

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its...

The price reductions for the life-saving medication come amid criticism that unaffordable insulin may constitute a human rights abuse.